Pregnancy

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development…

2 years ago

Veru to Present at the Jefferies Global Healthcare Conference

MIAMI, FL, May 22, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

2 years ago

First 1,000 Days Suncoast Initiative Powered by Unite Us Increases Access to Vital Support Services by 89%, Leading to 54% Reduction in Stress for Families in Need

New evaluation highlights an average increase of four mentally healthy days per month for expecting parents and families with young…

2 years ago

Institute for the Advancement of Minority Health Partners With CareSimple to Tackle Maternal & Infant Health in Rural Mississippi

The collaboration, part of HRSA's RMOMS program, harnesses innovative solutions to address disparities in maternal care, emphasizing early risk identification…

2 years ago

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

2 years ago

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

Veru to Present at the Jefferies Global Healthcare Conference

First 1,000 Days Suncoast Initiative Powered by Unite Us Increases Access to Vital Support Services by 89%, Leading to 54% Reduction in Stress for Families in Need

Institute for the Advancement of Minority Health Partners With CareSimple to Tackle Maternal & Infant Health in Rural Mississippi

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology

Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update